Cargando…
COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection?
Autores principales: | Clark, Nicole F., Taylor-Robinson, Andrew W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994343/ https://www.ncbi.nlm.nih.gov/pubmed/33777973 http://dx.doi.org/10.3389/fmed.2021.620175 |
Ejemplares similares
-
COVID-19 Therapy: Could a Chlorophyll Derivative Promote Cellular Accumulation of Zn(2+) Ions to Inhibit SARS-CoV-2 RNA Synthesis?
por: Clark, Nicole F., et al.
Publicado: (2020) -
Lymphopenia in SARS
por: Panesar, Nirmal S
Publicado: (2003) -
Conceptual Framework for SARS-CoV-2–Related Lymphopenia
por: Rahimmanesh, Ilnaz, et al.
Publicado: (2022) -
The Fate of the Chlorophyll Derivatives in Olives Preserved and/or Packaged in Presence of Exogenous Copper
por: Natella, Fausta, et al.
Publicado: (2023) -
Acute Pneumocystis jirovecii Pneumonia Due to Absolute Lymphopenia
por: Hilker, Eric, et al.
Publicado: (2022)